|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 14.28 USD | +0.92% |
|
+1.71% | -7.51% |
| 09-18 | KeyBanc Initiates NeuroPace at Overweight With $18 Price Target | MT |
| 08-13 | NeuroPace, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NPCE | Delayed | |
CBOE
| NPCE | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 14.64 | 19.29 | 18.35 |
| Spread/Res. | -2.46% | -25.97% | -22.18% |
| Spread/Supp. | +2.96% | +11.21% | +43.66% |
| Support | 13.87 | 12.84 | 9.94 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NPCE Stock
- Charts NeuroPace, Inc.
Select your edition
All financial news and data tailored to specific country editions
